Clinical Trials

Showing trials with last updates posted in 2014.

NCT00082784 | COMPLETED | PHASE1
93 participants

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-23
Start Date:
2004-03-31
Completion:
2012-10-31
Conditions
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Nodal Marginal Zone Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Diffuse Mixed Cell Lymphoma
  • Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Refractory Plasma Cell Myeloma
  • Splenic Marginal Zone Lymphoma
  • Waldenstrom Macroglobulinemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00072137 | TERMINATED | PHASE1
21 participants

Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy

Study Type:
INTERVENTIONAL
Last Updated:
2014-12-23
Start Date:
2003-10-31
Completion:
2009-12-31
Conditions
  • Bladder Adenocarcinoma
  • Bladder Squamous Cell Carcinoma
  • Bladder Urothelial Carcinoma
  • Recurrent Bladder Carcinoma
  • Stage I Bladder Cancer
  • Stage II Bladder Cancer
  • Stage III Bladder Cancer
  • Stage IV Bladder Cancer
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page